Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-SARS drug screening by molecular docking.

D-Q Wei1, R Zhang, Q-S Du

  • 1College of Life Science and Technology, Shanghai Jiaotong University, Shanghai, China. dqwei@sjtu.edu.cn

Amino Acids
|May 23, 2006
PubMed
Summary

Researchers identified three potential drug candidates for SARS-CoV Mpro inhibition through molecular docking and similarity searches. These compounds show promise for developing new antiviral therapies against SARS enzymes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Bronchiolar adenoma: a clinicopathological analysis of 15 cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2020
Same author

[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].

Zhonghua xin xue guan bing za zhi·2020
Same author

The Ca<sup>2+</sup> -regulated protein kinase CIPK1 integrates plant responses to phosphate deficiency in Arabidopsis thaliana.

Plant biology (Stuttgart, Germany)·2020
Same author

NF-κB inhibitor QNZ protects human chondrocyte degeneration by promoting glucose uptake through Glut4 activation.

European review for medical and pharmacological sciences·2020
Same author

Precision measurement of the neutral pion lifetime.

Science (New York, N.Y.)·2020
Same author

[Strengthening basic and clinical research on ocular infection caused by coronavirus].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2020

Area of Science:

  • Medicinal Chemistry
  • Computational Drug Discovery
  • Virology

Background:

  • Drug discovery relies on identifying novel compounds with therapeutic potential.
  • The SARS-CoV main protease (Mpro) is a critical target for antiviral drug development.
  • Computational methods accelerate the identification of potential drug candidates.

Purpose of the Study:

  • To identify novel inhibitors of the SARS-CoV main protease (Mpro).
  • To narrow down a large library of druggable compounds for docking studies.
  • To provide insights for developing potent inhibitors against SARS enzymes.

Main Methods:

  • 3D pharmacophore search identified an initial set of 1386 druggable compounds.
  • Similarity searching using MDL MACCS keys and Tanimoto coefficient (threshold 0.8) refined the set to 50 unique hits.

Related Experiment Videos

  • Molecular docking of 50 ligands to SARS-CoV Mpro was performed using AutoDock 3.011.

    • Main Results:

    • A similarity search yielded 50 unique hits and 103 conformers.
    • Molecular docking identified three promising compounds: C(28)H(34)O(4)N(7)Cl, C(21)H(36)O(5)N(6), and C(21)H(36)O(5)N(6).
    • Analysis of shared features and protein side chains offers insights into inhibitor development.

    Conclusions:

    • Three novel compounds demonstrate potential as SARS-CoV Mpro inhibitors.
    • The identified compounds warrant further investigation for antiviral drug development.
    • Structural insights can guide the design of more potent SARS enzyme inhibitors.